PUBLISHER: Grand View Research | PRODUCT CODE: 1405894
PUBLISHER: Grand View Research | PRODUCT CODE: 1405894
The global biliary stents market size is estimated to reach USD 197.96 million by 2030, based on a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.0% from 2024 to 2030. The market is experiencing robust growth, driven by the escalating incidence of biliary disorders and chronic liver diseases. In the U.S., liver cancer annually affects around 25,000 men and 11,000 women, resulting in a substantial mortality rate, according to the CDC report. This upward trajectory is further propelled by advancements in stent types, a growing geriatric population, heightened healthcare awareness, and a rising preference for minimally invasive procedures.
According to the NCBI article published in April 2023, a pivotal factor contributing to market expansion is the widespread adoption of endoscopic luminal stenting (ELS). ELS has emerged as a minimally invasive and highly effective solution for managing malignant obstructions in the gastrointestinal tract, particularly biliary obstructions. Its superiority over traditional modalities like radiotherapy and surgery positions it as a preferred first-line application in palliative and neoadjuvant settings.
The dynamic evolution of stent types, addressing the demand for heightened efficacy, safety, and adaptability to cutting-edge technologies, serves as a catalyst for the continued growth and relevance of the market. Despite these positive trends, the impact of reduced cancer screening initiatives during the COVID-19 pandemic has introduced challenges, leading to a notable decline in newly diagnosed cancer cases.